[Federal Register Volume 69, Number 205 (Monday, October 25, 2004)]
[Notices]
[Page 62295]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-23767]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances Notice of Application

    Pursuant to 21 CFR 1301.33(a), this is notice that on April 20, 
2004, Cody Laboratories, Inc., 301 Yellowstone Avenue, Cody, Wyoming 
82414, made application by renewal to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of the 
basic classes of controlled substances listed:

------------------------------------------------------------------------
                            Drug                               Schedule
------------------------------------------------------------------------
Amphetamine (1100).........................................           II
Methamphetamine (1105).....................................           II
Amobarbital (2125).........................................           II
Pentobarbital (2270).......................................           II
Secobarbital (2315)........................................           II
Cocaine (9041).............................................           II
Oxycodone (9143)...........................................           II
Dihydromorphine (9145).....................................           II
Hydromorphone (9150).......................................           II
Diphenoxylate (9170).......................................           II
Meperidine (9230)..........................................           II
Oxymorphone (9652).........................................           II
Sufentanil (9740)..........................................           II
Fentanyl (9801)............................................           II
------------------------------------------------------------------------

    The company plans to manufacture bulk materials for distribution to 
its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCD) and must be filed no later than December 27, 2004.

    Dated: October 18, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-23767 Filed 10-22-04; 8:45 am]
BILLING CODE 4410-09-P